Study Tag: Clinical Trial

  • February 24, 2021
    This study is investigating whether CT1812, a novel and promising therapeutic candidate can halt or slow the process of Alzheimer’s…
  • March 24, 2020
    Approximately fifty percent of people diagnosed with Alzheimer’s disease or other types of dementia will receive hospice care at the…
  • March 22, 2020
    Tau protein is an important target in Alzheimer’s disease (AD), and there is now strong evidence that tau in brain…
  • March 21, 2020
    AHEAD Study is a global multicenter clinical trial aimed at preventing memory loss due to Alzheimer’s disease, designed and conducted…
  • February 24, 2020
    The purpose of the Memory Improvement Through Nicotine Dosing (MIND) study is to determine whether daily transdermal nicotine (patch) will…
  • February 24, 2020
    The landmark Anti-Amyloid Treatment in Asymptomatic Alzheimer’s study (A4 Study) enrolled 1,169 healthy older adults with normal memory but who…
  • February 24, 2019
    The purpose of the SNIFF study is to find out whether a type of insulin, when administered as a nasal…
  • February 24, 2019
    The Connect study tested whether an oral, experimental drug, AZD0530 (saracatinib), would slow progression in early stage Alzheimer’s disease (AD).…
  • January 1, 2018
    The EARLY Trial was looking to determine the Efficacy and safety of atabecestat in participants who are Asymptomatic at Risk…